Form D · Biotechnology
Eleusis Holdings Ltd
New York, NY · CIK 0001911055
Offering snapshot reported Mar 4, 2022 · SEC filing
- Reported sold
- $465K Offering amount: $50M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2022 | Initial | $465,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-435893
Source: Form D, filed Mar 4, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bryan Clifton | Director |
| Robert M. Hershberg | Director |
| Joanna Grace Natasegara | Director |
| Shlomi Raz | Director |
| David Socks | Director |
| John Tucker | Director |
| Esther Van Den Boom | Director |
| Mary Frances Vernon | Director |
| Patrick John Stephen Vernon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
99 Wall Street, #2205
New York, NY, 10005
New York, NY, 10005